What You Should Know:
– AngelEye Health secures $9M Series C funding round led by Mountain Group Partners, with strategic investment from Nationwide Children’s Hospital and a new debt facility from Live Oak Bank.
– The capital will fuel the commercial launch of AIVision, an AI-driven monitoring tool designed to provide earlier safety insights for neonatal care teams. Currently serving over 350 hospitals and 20% of NICU families in the U.S., AngelEye is pivoting from family engagement tools to a comprehensive, intelligent inpatient environment.
From Livestream to Life-Saving AI: AngelEye Health Secures $9M to Redefine the Smart NICU
For over a decade, the “smart hospital” revolution has largely focused on adult acute care, optimizing everything from bed management to cardiac monitoring. However, a quiet transformation is taking place in one of the hospital’s most sensitive environments: the Neonatal Intensive Care Unit (NICU).
AngelEye Health, the Nashville-based company best known for its secure family livestreaming cameras, has announced the closing of a $9M Series C funding round led by existing investor Mountain Group Partners and notably includes Nationwide Children’s Hospital as a new strategic investor. Coupled with a complementary debt facility from Live Oak Bank, this capital injection signals a major shift in AngelEye’s strategy—moving beyond engagement to AI-driven clinical intelligence.
“Our team has remained focused on one mission: helping hospitals provide comprehensive support for clinical teams and families alike,” said Christopher Rand, CEO of AngelEye Health. “This funding gives us the ability to bring AIVision to market while continuing to scale the solutions that have already made us a trusted partner to hundreds of hospitals nationwide.”
Strategic Validation from a Pediatric Leader
The addition of Nationwide Children’s Hospital to the cap table is a significant endorsement of AngelEye’s clinical utility. In the health tech sector, investment from a provider organization often validates that a solution solves real-world workflow problems rather than just offering theoretical benefits.
As part of the investment, Luke Brown, Vice President of Finance and Treasury at Nationwide Children’s, will join AngelEye’s Board of Directors as an observer.
“AngelEye’s mission to empower families and equip care teams in the NICU and pediatric settings aligns strongly with our goals as a pediatric health leader,” Brown noted, underscoring the shift toward technologies that integrate family empowerment directly with clinical outcomes.
The Next Frontier: AIVision
While AngelEye has built a footprint in over 350 hospitals—serving approximately 20% of NICU families in the U.S.—its legacy has been defined by communication tools like the CameraSystem and MilkTracker.
The Series C funding is explicitly earmarked to accelerate the deployment of AIVision. This moves the platform from passive observation to active, intelligent monitoring. By applying computer vision and machine learning to the video feeds already present in the NICU, AngelEye aims to provide care teams with proactive risk identification and earlier insights into patient status.
This evolution mirrors a broader trend in medtech: hardware-first companies evolving into data platforms. By layering AI onto its existing camera infrastructure, AngelEye effectively upgrades the capabilities of every bed in its network without requiring a massive hardware overhaul.
